EUVIMEDEUVIMED entdecken
Open Access

Lenvatinib in radioiodine-refractory differentiated thyroid cancer: a real-world institutional analysis

Sueyoshi Moritani, Masao Takenobu, Masakazu Yasunaga, Taihei Fujii, Mako Moritani, Rie Bando, Shoko Oda, Yuki Harada, Hiroya Kitano

Endocrine Journal · 2026

DOI: 10.1507/endocrj.ej25-0539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2026. Verfasst von Sueyoshi Moritani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Otolaryngology, Head and Neck Thyroid Surgery, Omi Medical Center, Shiga 525-8585, Japan. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Phenylurea Compounds, Quinolines, Antineoplastic Agents. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsPhenylurea CompoundsQuinolinesAntineoplastic AgentsHumansFemaleMaleIodine RadioisotopesRetrospective StudiesMiddle AgedAdultAgedLung NeoplasmsTreatment OutcomeProgression-Free Survival

Stichwörter der Autor:innen

LenvatinibPlanned drug holidayRadioiodine-refractory differentiated thyroid cancerReal-world studyToxicity management

Substanzen

lenvatinibPhenylurea CompoundsIodine RadioisotopesQuinolinesAntineoplastic Agents

Autor:innen und Institutionen

  • Center for Otolaryngology, Head and Neck Thyroid Surgery, Omi Medical Center, Shiga 525-8585, Japan.
  • Department of Pharmacy, Omi Medical Center, Shiga 525-8585, Japan.

Zitieren

APA

Moritani, S., Takenobu, M., Yasunaga, M., Fujii, T., Moritani, M., Bando, R., Oda, S., Harada, Y., & Kitano, H. (2026). Lenvatinib in radioiodine-refractory differentiated thyroid cancer: a real-world institutional analysis. Endocrine Journal. https://doi.org/10.1507/endocrj.ej25-0539

Vancouver

Moritani S, Takenobu M, Yasunaga M, Fujii T, Moritani M, Bando R, et al. Lenvatinib in radioiodine-refractory differentiated thyroid cancer: a real-world institutional analysis. Endocrine Journal. 2026. doi:10.1507/endocrj.ej25-0539

BibTeX
@article{Moritani2026,
  author = {Moritani, Sueyoshi and Takenobu, Masao and Yasunaga, Masakazu and Fujii, Taihei and Moritani, Mako and Bando, Rie and Oda, Shoko and Harada, Yuki and Kitano, Hiroya},
  title = {Lenvatinib in radioiodine-refractory differentiated thyroid cancer: a real-world institutional analysis},
  journal = {Endocrine Journal},
  year = {2026},
  doi = {10.1507/endocrj.ej25-0539}
}
Kostenlos starten →